AKT1 and type 1 diabetes mellitus: Our findings revealed a significant difference in the median relative expression level of miR-410 between the T1DM and control groups with upregulation of the marker in T1DM patients, Targets like vascular endothelial growth factor (VEGFA), insulin-like growth factor (IGF-1) receptor, and serine/threonine kinase 1 (AKT1) were linked to this miRNA, according to the KEGG pathway enrichment analysis [27].